Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Benzer Materyaller

• Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.
  Yazar:: Keulen, W, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Differential Removal of Thymidine Nucleotide Analogues from Blocked DNA Chains by Human Immunodeficiency Virus Reverse Transcriptase in the Presence of Physiological Concentrations of 2′-Deoxynucleoside Triphosphates
  Yazar:: Meyer, Peter R., ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.
  Yazar:: Oude Essink, B B, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
  Yazar:: Bertoletti, Nicole, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Deoxynucleoside Triphosphate Incorporation Mechanism of Foamy Virus (FV) Reverse Transcriptase: Implications for Cell Tropism of FV
  Yazar:: Santos-Velazquez, Jose, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)